The European response to the WHO call cervical cancer as a public health problem

Last updated on 15-6-2023 by Marie Malingreau

Public Access


Peer reviewed scientific article



The age‐standardised incidence of cervical cancer in Europe varies widely (between 3 and 25/100000 women‐years) in 2018. HPV vaccine coverage is low in countries with the highest incidence and screening performance is heterogeneous among European countries. A broad group of delegates of scientific professional societies and cancer organisations endorse the principles of the WHO call to eliminate cervical cancer as a public health problem, also in Europe. All European nations should, by 2030, reach at least 90% HPV vaccine coverage among girls by the age of 15 years and also boys, if cost‐e…

Associated health topics:

QR code

QR code for this page URL